Wiley
Wiley.com
Print this page Share

Communicable Disease Control and Health Protection Handbook, 3rd Edition

ISBN: 978-1-4443-3567-5
456 pages
March 2012, Wiley-Blackwell
Communicable Disease Control and Health Protection Handbook, 3rd Edition (1444335677) cover image
Health protection professionals need rapid access to authoritative and easy-to-use information to ensure their actions are based on international best practice. This is precisely what the Communicable Disease Control and Health Protection Handbook does. This concise and practical handbook is an essential guide for all those who have responsibility for the identification and control of infectious disease. 

In the past five years, there have been many major changes in health protection practice, and significant scientific progress in the field, all of which are reflected in this new edition of the popular Communicable Disease Control and Health Protection Handbook. All chapters have been updated in line with recent changes in epidemiology, new guidelines for control and administrative changes. Basic principles of communicable disease control and health protection, major syndromes, control of individual infections, main services and activities, organizational arrangements for all EU countries and sources of further information are covered. A new chapter on pandemic planning has been included, and the influenza chapter has been expanded to cover seasonal, avian and pandemic flu. 

Communicable Disease Control and Health Protection Handbook is an indispensible companion for all those who are engaged in health protection, including public health physicians, epidemiologists, infection control nurses, microbiologists and trainees in the field.

See More
Foreword.

Abbreviations.

Section 1: Introduction.

1.1 How to use this book.

1.2 Basic Concepts in the Epidemiology and Control of Infectious Disease.

1.3 Health Protection on-call.

Section 2: Common topics.

2.1 Meningitis and meningism.

2.2 Gastrointestinal infection.

2.3 Community acquired pneumonia.

2.4 Rash in pregnancy.

2.5 Rash and fever in children.

2.6 Illness in returning travellers.

2.7 Sexually Transmitted Infections.

2.8 Jaundice.

2.9 Infection in the immunocompromised.

2.10 Blood borne viral infections.

2.11 Vaccine Queries.

2.12 Individual measures against infections.

Section 3: Diseases.

3.1 Amoebic dysentery.

3.2 Anthrax.

3.3 Bacillus cereus.

3.4 Botulism.

3.5 Brucellosis.

3.6 Burkholderia.

3.7 Campylobacter.

3.8 Chickenpox and shingles (varicella-zoster infections).

3.9 Chikungunya.

3.10 Chlamydophila pneumoniae.

3.11 Chlamydophila psittaci.

3.12 Chlamydia trachomatis (genital).

3.13 Cholera.

3.14 CJD and other human transmissible spongiform encephalopathies.

3.15 Clostridium difficile.

3.16 Clostridium perfringens.

3.17 Coxsackievirus infections.

3.18 Cryptosporidiosis.

3.19 Cyclosporiasis.

3.20 Cytomegalovirus.

3.21 Dengue fever.

3.22 Diphtheria.

3.23 Encephalitis, acute.

3.24 Enterococci, including glycopeptide-resistant enterococci (GRE).

3.25 Epstein–Barr virus.

3.26 Escherichia coli O157 (and other E. coli gastroenteritis).

3.27 Giardiasis.

3.28 Gonorrhoea, syphilis and other acute STIs.

3.29 Hantavirus.

3.30 Head lice.

3.31 Helicobacter pylori.

3.32 Hepatitis A.

3.33 Hepatitis B.

3.34 Hepatitis C.

3.35 Delta hepatitis.

3.36 Hepatitis E.

3.37 Herpes simplex.

3.38 Haemophilus influenzae type b (Hib).

3.39 HIV.

3.40 Influenza.

3.41 Japanese B encephalitis.

3.42 Kawasaki Syndrome.

3.43 Legionellosis.

3.44 Leprosy.

3.45 Leptospirosis.

3.46 Listeria.

3.47 Lyme disease.

3.48 Malaria.

3.49 Measles.

3.50 Meningococcal infection.

3.51 Molluscum contagiosum.

3.52 MRSA (methicillin-resistant Staphylococcus aureus).

3.53 Mumps.

3.54 Mycoplasma.

3.55 Norovirus.

3.56 Paratyphoid fever.

3.57 Parvovirus B19 (fifth disease).

3.58 Plague.

3.59 Pneumococcal infection.

3.60 Poliomyelitis.

3.61 Q fever.

3.62 Rabies.

3.63 Relapsing Fever.

3.64 Respiratory syncytial virus (RSV).

3.65 Ringworm.

3.66 Rotavirus.

3.67 Rubella.

3.68 Salmonellosis.

3.69 Severe Acute Respiratory Syndrome (SARS).

3.70 Scabies

3.71 Shigella.

3.72 Smallpox.

3.73 Staphylococcal food poisoning.

3.74 Streptococcal infections.

3.75 Tetanus.

3.76 Threadworms.

3.77 Tick-borne encephalitis.

3.78 Toxocara.

3.79 Toxoplasmosis.

3.80 Tuberculosis.

3.81 Tularaemia.

3.82 Typhoid fever.

3.83 Rickettsial infections (incl. Typhus) Ehrlichia and Bartonella.

3.84 Vibrio parahaemolyticus.

3.85 Viral haemorrhagic fevers.

3.86 Warts and verrucae.

3.87 West Nile Virus.

3.88 Whooping cough.

3.89 Yellow fever.

3.90 Yersiniosis.

3.91 Other organisms.

Section 4: Services and organisations.

4.1 Surveillance of communicable disease.

4.2 Managing infectious disease incidents and outbreaks.

4.3 Infection Prevention and Control in the Community.

4.4 Healthcare Associated Infection.

4.5 Antimicrobial Resistance.

4.6 Risks to and from Health Care Workers.

4.7 Co-ordination of immunisation services.

4.8 Services for sexual health and HIV infection.

4.9 Services for tuberculosis control.

4.10 Travel Health.

4.11 Pandemic Preparedness and the Influenza A H1N1 2009 Pandemic.

4.12 Non-infectious environmental hazards.

4.13 Managing acute chemical incidents.

4.14 Managing acute radiation incidents.

4.15 Deliberate release of biological, chemical or radiological agents.

4.16 Media Relations and Crisis Communication.

4.17 Clinical Governance and Audit.

4.18 Global health.

Section 5: Communicable disease control in Europe.

5.1 WHO and International Health Regulations (IHR).

5.2 Collaboration within the European Union.

5.3 Detailed national example: organisational arrangements for health protection: England, 2010.

5.4 Austria.

5.5 Belgium.

5.6 Bulgaria.

5.7 Cyprus.

5.8 Czech Republic.

5.9 Denmark.

5.10 Estonia.

5.11 Finland.

5.12 France.

5.13 Germany.

5.14 Greece.

5.15 Hungary.

5.16 Iceland.

5.17 Ireland.

5.18 Italy.

5.19 Latvia.

5.20 Lithuania.

5.21 Luxembourg.

5.22 Malta.

5.23 The Netherlands.

5.24 Norway.

5.25 Poland.

5.26 Portugal.

5.27 Romania.

5.28 Slovakia.

5.29 Slovenia.

5.30 Spain.

5.31 Sweden.

5.32 Switzerland.

5.33 United Kingdom.

Appendix 1 Useful addresses and telephone numbers.

Appendix 2 Guidance documents and books.

Index.

See More
Jeremy Hawker is Regional Epidemiologist for the Health Protection Agency, West Midlands; Registrar of the UK Faculty of Public Health, UK

Norman Begg is Chief Medical Officer, GlaxoSmithKline Biologicals, Wavre, Belgium

Iain Blair is Associate Professor, Department of Community Medicine, Faculty of Medicine and Health Sciences, United Arab Emirates University

Ralf Reintjes is Professor of Epidemiology and Public Health Surveillance, Hamburg, Germany; Adjunct Professor of Infectious Disease Epidemiology, Tampere, Finland

Julius Weinberg is Vice Chancellor, Kingston University, London, UK

Professor Karl Ekdahl is Head of Public Health Capacity and Communication Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

See More

Related Titles

Back to Top